ABSTRACT
Biotinidase deficiency (BTD) is a treatable, inherited metabolic disorder commonly characterised by alopecia, dermatitis, seizures and developmental delay. It can also manifest as optic neuritis and myelitis; however, these are infrequently described in the literature. We report three cases who presented with quadriplegia and vision loss, initially managed as neuromyelitis optica spectrum disorder (NMOSD), based on neuroimaging findings. Two of them initially responded to immune therapy but relapsed after a few months, while one case showed no clinical improvement with immune therapy. The clinical presentation and neuroimaging findings in all three cases were consistent with NMOSD, leading to a delayed diagnosis of BTD. Antiaquaporin4 and antimyelin oligodendrocyte glycoprotein antibodies were negative in all patients. Urine organic acids reported raised markers of biotinidase or holocarboxylase synthase deficiency. Two of them had a dramatic response to biotin supplementation, showing significant improvement in motor function and vision.
Subject(s)
Biotinidase Deficiency , Neuromyelitis Optica , Humans , Biotinidase Deficiency/diagnosis , Biotinidase Deficiency/drug therapy , Biotinidase Deficiency/complications , Neuromyelitis Optica/diagnosis , Female , Diagnosis, Differential , Male , Biotin/therapeutic use , Biotin/administration & dosage , Magnetic Resonance Imaging , Quadriplegia/etiology , ChildABSTRACT
We report a case of a boy in his middle childhood who presented with inspiratory stridor and lactic acidosis and was subsequently diagnosed with partial biotinidase deficiency. Fibreoptic laryngoscope showed paradoxical vocal fold mobility.Partial biotidinase deficiency is an inherited disorder in which the body is unable to recycle the vitamin biotin. It may result in clinical consequences and can be easily treated with biotin but need a high index of suspicion to diagnose. The main symptoms include ataxia, seizures, hypotonia, psychomotor retardation, alopecia, skin rash, progressive deafness, optic atrophy and life-threatening episodes of metabolic acidosis. Laryngeal stridor is an uncommon presentation, but it is reversible in case of biotinidase deficiency. Invasive procedure like tracheostomy has not been shown to enhance outcomes.
Subject(s)
Biotinidase Deficiency , Respiratory Sounds , Humans , Male , Respiratory Sounds/etiology , Biotinidase Deficiency/complications , Biotinidase Deficiency/diagnosis , Biotin/therapeutic use , Biotin/administration & dosage , Laryngoscopy , ChildABSTRACT
INTRODUCTION: Biotinidase deficiency (BD) is an inherited autosomal recessive metabolic disorder. BD has been associated with optic nerve atrophy, eye infections, and retinopathy. The most prevalent ophthalmic manifestation of BD is optic atrophy, which might be misdiagnosed as multiple sclerosis or neuromyelitis optica, especially in late-onset BD cases. METHODS: In this article, we report a 9-year-old boy with gradual vision loss. Ophthalmologic examination, Brain MRI, and several laboratory tests such as Aquaporin-4 IgG level and biotinidase level were done on the patient. RESULTS: Bilateral optic atrophy and impaired visual acuity were detected on examination. The patient had a biotin level of 1.25 U/min/ml (normal range 3-9 U/min/ml), favoring the BD. CONCLUSION: In this study, we report a 9-year-old boy with vision loss diagnosed with BD. We also reviewed the literature to highlight the ophthalmic manifestations of BD. Ophthalmologists must consider BD in children with unexplained ophthalmologic complaints, especially when other characteristic signs of BD (e.g., developmental delay, seizure) are present. Also, patients with BD should undergo regular annual ophthalmologic examinations to be checked for any signs of eye involvement.
Subject(s)
Biotinidase Deficiency , Optic Atrophy , Male , Child , Humans , Biotinidase Deficiency/complications , Biotinidase Deficiency/diagnosis , Biotinidase , Biotin , Vision DisordersABSTRACT
A 10-year-old girl initially diagnosed with functional visual loss was later diagnosed with progressive optic atrophy. Directed questioning at 13 years of age revealed difficulty hearing that had not been noted by the parents. Whole exome sequencing and subsequent metabolic testing confirmed biotinidase deficiency. Although biotinidase deficiency classically manifests in early childhood with multiple manifestations, such as seizures and failure to thrive, a delayed-onset form can present primarily as juvenile progressive optic atrophy. Early diagnosis is critical because biotin supplementation prevents disease and deterioration.
Subject(s)
Biotinidase Deficiency , Optic Atrophy , Adolescent , Biotin/therapeutic use , Biotinidase , Biotinidase Deficiency/complications , Biotinidase Deficiency/diagnosis , Biotinidase Deficiency/drug therapy , Child , Female , Humans , Optic Atrophy/diagnosis , Optic Atrophy/etiology , Vision Disorders/diagnosis , Vision Disorders/etiologyABSTRACT
Biotinidase deficiency is a rare hereditary metabolic disease. Only a few cases have been reported in China, almost all of which have been in the pediatric population. We report a case of a girl with characteristic skin and hair findings with a negative family history, although her grandparents were consanguineous. The metabolites in the proband's blood and urine increased prominently, and the percentage of biotinase was 1.168%, much lower than normal. Genotyping identified two heterozygous mutations, which were C.1457T>A (p.L486Q) and C.1491dupT (p.L498Ffs*13) in the BTD gene. The diagnosis of biotinidase deficiency was established. No relevant reports about the missense mutation at the mutation site C.1457T>A (p.L486Q) of the BTD gene have been retrieved. Biotin replacement therapy was administered in the dose of 20 mg/d. The dermatitis subsided after 1 month, and the hair color was almost normal after 3 months. This reminds dermatologists to include biotinidase deficiency in their clinical differential when faced with children's intractable dermatitis, yellow hair, and alopecia.
Subject(s)
Alopecia/etiology , Biotin/administration & dosage , Biotin/metabolism , Biotinidase Deficiency/complications , Biotinidase Deficiency/diagnosis , Biotinidase Deficiency/genetics , Biotinidase/genetics , Eczema/etiology , Hair Color , Biotinidase Deficiency/drug therapy , Child , Female , Heterozygote , Humans , Mutation , Treatment OutcomeABSTRACT
We present a case of biotinidase deficiency mimicking neuromyelitis optica spectrum disorder (NMOSD) with tetraparesis and transverse myelitis, who was diagnosed with profound biotinidase deficiency after developing optic atrophy and hearing loss before the age of one year, and was untreated for six months. Biotinidase deficiency should be considered in the differential diagnosis of seronegative NMOSD.
Subject(s)
Biotinidase Deficiency , Myelitis, Transverse , Neuromyelitis Optica , Aquaporin 4 , Biotinidase Deficiency/complications , Biotinidase Deficiency/diagnosis , Diagnosis, Differential , Humans , Infant , Neuromyelitis Optica/diagnosisSubject(s)
Acrodermatitis/etiology , Biotin/therapeutic use , Biotinidase Deficiency/complications , Seizures/etiology , Zinc/deficiency , Acrodermatitis/drug therapy , Alopecia/etiology , Biotinidase/blood , Biotinidase Deficiency/diagnosis , Biotinidase Deficiency/drug therapy , Child , Humans , Infant, Newborn , Male , Neonatal Screening , Skin/pathologyABSTRACT
INTRODUCTION: Biotinidase deficiency is an inherited disorder of biotin metabolism that is untreated may present within the first few month of life. OBJECTIVE: We report the exceptional observation of a biotinidase deficiency in Morocco. The rarity of this pathology, its age of onset, its mode of revelation and the lack of treatment in Morocco make the particularity of this observation. OBSERVATION: A newborn child born from a 24-year-old mother, followed by an estimated pregnancy of 37 weeks of amenorrhea according to the Farr score (morphological maturation score used for the dating of the pregnancy term). The infant presented at 7 days of life with a cutaneous-mucous eruption with icithiosic dry erythroderma of interest to the trunk, the face, the scalp associated with alopecia and depilation of the eyebrow. The biotinoidase deficiency was confirmed by its low serum concentration at 49 nka / l. The newborn died at 20 days of life before starting the specific treatment. CONCLUSION: Biotinidase deficiency is a rare condition requiring early screening and rapid management. The delay in diagnosis and the unavailability of treatment in Morocco can have fatal consequences.
Subject(s)
Biotin/supply & distribution , Biotinidase Deficiency/diagnosis , Vitamin B Complex/supply & distribution , Age of Onset , Alopecia/etiology , Alopecia/physiopathology , Biotin/therapeutic use , Biotinidase Deficiency/complications , Biotinidase Deficiency/drug therapy , Biotinidase Deficiency/physiopathology , Consanguinity , Dermatitis, Exfoliative/etiology , Dermatitis, Exfoliative/physiopathology , Eyebrows , Fatal Outcome , Health Services Accessibility , Humans , Ichthyosis/etiology , Ichthyosis/physiopathology , Infant, Newborn , Intensive Care Units, Neonatal , Male , Morocco , Muscle Hypotonia/etiology , Muscle Hypotonia/physiopathology , Myoclonus/etiology , Myoclonus/physiopathology , Rare Diseases , Vitamin B Complex/therapeutic useABSTRACT
Aim: Severe biotin deficiency associated with biotinidase enzyme deficiency in newborns is seen as severe neurological problems and hearing loss. However, the effect on the infant of deficiencies in the maternal diet during pregnancy are not clear. Material and methods: The study included 16 female Wistar albino rats and 4 male Wistar albino rats, that were mated and then the females were separated into 4 groups. At 40 days after the birth, 3 pups were selected from each group, and these 12 pups were evaluated with DPOAE and ABR electrophysiologically and the cochlea was examined ultrastructurally with electron microscopy. Results: In the DPOAE evaluation, At 8000 and 11,000 Hz, the signal-noise ratios in the B-N and B-B groups were statistically significantly higher (p < .05). In ABR, lengthening of the latency periods was determined in all the waves at both 8 and 16 kHz in the B-B group. When the IPL periods were examined, lengthening in IPL 1-5 was statistically significant in the B-B group only at 8 kHz. Conclusions: Biotin can be said to have an effect on hearing pathways. However, specifically where on the hearing pathways that biotin is involved has not been clarified.
Subject(s)
Auditory Pathways/drug effects , Biotinidase Deficiency/complications , Fetus/drug effects , Animals , Auditory Pathways/embryology , Auditory Pathways/ultrastructure , Disease Models, Animal , Evoked Potentials, Auditory, Brain Stem , Female , Lactation , Male , Microscopy, Electron , Organ of Corti/ultrastructure , Pregnancy , Rats, WistarABSTRACT
INTRODUCTION: Nodding syndrome (NS) is associated with high anion gap, biotinidase and acetyl carnitine deficiency, vitamin B6 and D deficiency and internal displacement. The objective of this study was to conduct a metabolic analysis on NS children and review literature on its similarities with ASD. METHODS: We conducted biochemical analysis on blood and urine of NS children at Hope for HumaNs (HfH) centre in 2014 and reviewed literature on its similarities with ASD. Ethical approval was obtained from an IRB. Data analysis was conducted using STATA version 12 and a p-value less than 0.05 was considered significant. RESULTS: We found biotinidase deficiency in NS with a mean 1.98 95% CI(1.61, 2.34; p < 0.001); Acetyl carnitine deficiency 16.92 95% CI(16.10,17.75; p<0.001); Low BMI-for-age 16.92 95% CI(16.10,17.75; p = 0.42); Age 14.08 95% CI(0.78,4.660; p = 0.007); IDP duration 4.82 95% CI(4.48, 5.21; p = 0.92); Age at NS onset 8.02 95% CI(7.03, 9.01; p = 0.001); NS associated with multiple nodding episodes (χ2)=22.15, p=0.005; NS siblings with NS (χ2) = 9.68, p = 0.004; NS were in IDPs (χ2) = 22.15, p = 0.005. CONCLUSION: These findings are indicative that NS is associated with biotinidase and acetyl carnitine deficiency, IDPs, and environmental exposures. There are no new cases of NS reported by Ugandan MOH and WHO since 2012 when the IDP camps were disbanded and communities resettled in their own communities and feed on their own grown foods. Perhaps NS may be akin to Autism Spectrum Disorder (ASD). This finding will help support all efforts towards the treatment and rehabilitation of NS children.
Subject(s)
Acetylcarnitine/deficiency , Autism Spectrum Disorder/epidemiology , Biotinidase Deficiency/epidemiology , Nodding Syndrome/epidemiology , Adolescent , Autism Spectrum Disorder/physiopathology , Biotinidase Deficiency/complications , Child , Environmental Exposure/adverse effects , Female , Humans , Male , Nodding Syndrome/etiology , Nodding Syndrome/physiopathology , Uganda/epidemiology , Young AdultSubject(s)
Biotin/pharmacology , Biotinidase Deficiency , Epilepsy , Vitamin B Complex/pharmacology , Biotin/administration & dosage , Biotinidase Deficiency/complications , Biotinidase Deficiency/diagnosis , Biotinidase Deficiency/drug therapy , Biotinidase Deficiency/physiopathology , Epilepsy/diagnosis , Epilepsy/drug therapy , Epilepsy/etiology , Epilepsy/physiopathology , Humans , Infant , Male , Spasms, Infantile/physiopathology , Vitamin B Complex/administration & dosageABSTRACT
Dogruel D, Bulut FD, Yilmaz M, Önenli-Mungan N, Altintas DU. Coexistence of 2 rare autosomal recessively inherited disorders manifesting with immune deficiency; IL-12 receptor ß1 and biotinidase deficiencies. Turk J Pediatr 2018; 60: 584-587. In this report, we described an infant with both partial biotinidase and IL-12Rß1 deficiencies as these two entities are rare and unrelated inherited disorders. One-month-old girl was diagnosed as partial biotinidase deficiency with newborn screening programme. Mutation analysis revealed a compound heterozygous mutation BTD: c.1330G > C (p.Val444Leu) / c.196_197dupCATC (p.Leu69HisfsTer24). At the age of 6 months, a nodule on her left axilla with purulent discharge was noticed which was related to BCG vaccination. A mutational analysis revealed a homozygous c.783+1G > A mutation on IL-12Rß1 gene. Interferon-gamma and anti-tuberculosis treatment were initiated together and the nodule with purulent discharge regressed dramatically. Here, we want to emphasize consideration of coexistence of two rare autosomal recessively inherited diseases in a patient due to the high rate of consanguinity in our country.
Subject(s)
Biotinidase Deficiency/complications , Immunologic Deficiency Syndromes/diagnosis , Receptors, Interleukin-12/deficiency , Antitubercular Agents/therapeutic use , Biotinidase Deficiency/genetics , DNA Mutational Analysis/methods , Female , Humans , Immunologic Deficiency Syndromes/genetics , Infant , Infant, Newborn , Interferon-gamma/therapeutic use , Mutation , Neonatal Screening/methods , Receptors, Interleukin-12/geneticsABSTRACT
Biotinidase deficiency is characterized by severe neurological manifestations as hypotonia, lethargy, ataxia, hearing loss, seizures and developmental retardation in its classical form. Late-onset biotinidase deficiency presents distinctly from the classical form such as limb weakness and vision problems. A 14-year-old boy presented with progressive vision loss and upper limb weakness. The patient was initiated steroid therapy with a preliminary diagnosis of neuromyelitis optica spectrum disorder due to the craniospinal imaging findings demonstrating optic nerve, brainstem and longitudinally extensive spinal cord involvement. Although the patient exhibited partial clinical improvement after pulse steroid therapy, craniocervical imaging performed one month after the initiation of steroid therapy did not show any regression. The CSF IgG index was <0.8 (normal: <0.8), oligoclonal band and aquaporin-4 antibodies were negative. Metabolic investigations revealed a low biotinidase enzyme activity 8% (0.58 nmoL/min/mL; normal range: 4.4 to 12). Genetic testing showed c.98-104delinsTCC and p.V457 M mutations in biotinidase (BTD) gene. At the third month of biotin replacement therapy, control craniospinal MRI demonstrated a complete regression of the lesions. The muscle strength of the case returned to normal. His visual acuity was 7/10 in the left eye and 9/10 in the right. The late-onset form of the biotinidase deficiency should be kept in mind in all patients with myelopathy with or without vision loss, particularly in those with inadequate response to steroid therapy. The family screening is important to identify asymptomatic individuals and timely treatment.
Subject(s)
Biotin/therapeutic use , Biotinidase Deficiency/diagnostic imaging , Neuromyelitis Optica/diagnostic imaging , Spinal Cord Diseases/diagnostic imaging , Vision Disorders/diagnostic imaging , Adolescent , Biotinidase Deficiency/complications , Biotinidase Deficiency/drug therapy , Diagnosis, Differential , Humans , Male , Neuromyelitis Optica/complications , Neuromyelitis Optica/drug therapy , Spinal Cord Diseases/complications , Spinal Cord Diseases/drug therapy , Treatment Outcome , Vision Disorders/complications , Vision Disorders/drug therapyABSTRACT
OBJECTIVE: An analysis of clinical and paraclinical symptomatology of three cases of infant epilepsy due to biotinidase deficiency is presented. MATERIAL AND METHODS: The diagnosis took 4 months in the first case and 1 day in the last one. RESULTS AND CONCLUSION: It is emphasized that early diagnosisbased on knowing the reference signs of this inherited metabolic disease provides an opportunity to avoid patient's disability or death.